Back
Phathom Pharmaceuticals Vs. Apogee Enterprises Industry Stock Comparison
Buy
55
PHAT
Phathom Pharmaceuticals
Last Price:
10.24
Seasonality Move:
0.35%
Sell
49
APOG
Apogee Enterprises
Last Price:
61.66
Seasonality Move:
1.82%
Buy
55
Phathom Pharmaceuticals (PHAT)
is a Buy
Is Phathom Pharmaceuticals a Buy, Sell or Hold?
- The current Phathom Pharmaceuticals [PHAT] share price is $10.81. The Score for PHAT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- PHAT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
Apogee Enterprises (APOG)
is a Sell
Is Apogee Enterprises a Buy, Sell or Hold?
- The current Apogee Enterprises [APOG] share price is $61.72. The Score for APOG is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- APOG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PHAT Stock Price Chart
What is Phathom Pharmaceuticals's stock price today?
-
The Phathom Pharmaceuticals share price today is $10.81
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PHAT is experiencing buying pressure, which is a positive indicator for future bullish movement.
APOG Stock Price Chart
What is Apogee Enterprises's stock price today?
-
The Apogee Enterprises share price today is $61.72
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APOG is experiencing selling pressure, which indicates risk of future bearish movement.
PHAT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.07 | Buy |
Relative Strength Index (14 RSI): | 52.21 | Buy |
Chaikin Money Flow: | 398287 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.04 - 11.24) | Buy |
Bollinger Bands (100): | (8.65 - 11.09) | Buy |
APOG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.49 | Sell |
Relative Strength Index (14 RSI): | 47.91 | Sell |
Chaikin Money Flow: | -255027 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (60.63 - 64.47) | Sell |
Bollinger Bands (100): | (56.39 - 63.89) | Buy |
PHAT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.72 | Buy |
20-day SMA: | 10.78 | Buy |
50-day SMA: | 10.25 | Buy |
200-day SMA: | 9.27 | Buy |
8-day EMA: | 10.67 | Buy |
20-day EMA: | 10.69 | Buy |
50-day EMA: | 10.4 | Buy |
200-day EMA: | 9.98 | Buy |
APOG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 61.17 | Buy |
20-day SMA: | 61.78 | Sell |
50-day SMA: | 63.27 | Sell |
200-day SMA: | 54.28 | Buy |
8-day EMA: | 61.72 | Sell |
20-day EMA: | 62.09 | Sell |
50-day EMA: | 62.03 | Sell |
200-day EMA: | 56.12 | Buy |
Phathom Pharmaceuticals Earnings Growth & PHAT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.26 per share, an increase next quarter of $0.34 per share, a decrease this year of $1.15 per share, and an increase next year of $1.18 per share.
Apogee Enterprises Earnings Growth & APOG Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.06 per share, an increase this year of $0.67 per share, and an increase next year of $0.11 per share.
Phathom Pharmaceuticals Technical Analysis
Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Apogee Enterprises Technical Analysis
Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |